A number of recent studies have investigated various modifications of sulfonamides, for example, multitarget agents for the inhibition of AChE enzyme [49], multifunctional agents for Alzheimer’s disease [50], and/or an in vivo active reversible BChE inhibitor [51]. This evidence concerns the gene BCHE and Alzheimer disease.